<i>BRCA1</i> and <i>BRCA2</i> mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

Mutation prevalence was found to be high among women who were referred for clinical BRCA1 and BRCA2 testing, and the risk was similar across diverse ethnicities. BRCA1 and BRCA2 testing is integral to cancer risk assessment in all high-risk women.